By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Addex Therapeutics 

12, Chemin Des Aulx
1228 Plan-les-Ouates
Geneva      Switzerland
Phone: 41-22-884-1555 Fax: 41-22-884-1556


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Addex Therapeutics (ADXN.SW) Collaborators Published New Data Supporting The Role Of Negative Allosteric Modulators Of Follicle Stimulating Hormone And Luteinizing Hormone Receptors In Reproductive Health 9/20/2016 9:14:43 AM
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Positive Results In Highly Translational Preclinical Model Of Spasticity 7/27/2016 9:33:32 AM
LifeSci Capital Issues Equity Research Report On Addex Therapeutics (ADXN.SW) 7/20/2016 9:35:11 AM
Addex Therapeutics (ADXN.SW) Shareholders Approved All Board Proposals At 2016 Annual General Meeting 6/24/2016 9:04:29 AM
Addex Therapeutics (ADXN.SW) mGluR4 And mGluR7 Programs Demonstrate Potential In Preclinical Models Of Neurodegenerative And Psychiatric Diseases 6/13/2016 9:25:51 AM
Addex Therapeutics (ADXN.SW) ADX71441 Demonstrates Positive Results In Non-Human Primate Model Of Cocaine Addiction 6/9/2016 12:38:54 PM
Van Leeuwenhoeck Issues Research Note On Addex Therapeutics (ADXN.SW) 6/8/2016 11:34:46 AM
Addex Therapeutics (ADXN.SW) Annual General Meeting Scheduled For 23 June 2016 6/2/2016 9:16:37 AM
Addex Therapeutics (ADXN.SW) Dipraglurant Positive Phase 2 Data In PD-LID Published In Leading Peer Reviewed Journal Of The Movement Disorder Society 6/2/2016 9:10:32 AM
Addex Therapeutics (ADXN.SW) Increases Issued Share Capital And Creates Treasury Shares 5/31/2016 10:09:21 AM
12345678910...
//-->